kabutan

Mochida Pharmaceutical Co.,Ltd.(4534) Summary

4534
TSE Prime
Mochida Pharmaceutical Co.,Ltd.
3,545
JPY
-5
(-0.14%)
Jan 29, 3:30 pm JST
23.17
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
3,525.5
Jan 29, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
23.2
PBR
0.93
Yield
2.26%
Margin Trading Ratio
2.86
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
3,515 JPY 22.95 USD
Previous Close Jan 28
3,550 JPY 23.25 USD
High Jan 29, 3:30 pm
3,545 JPY 23.17 USD
Low Jan 29, 9:05 am
3,455 JPY 22.57 USD
Volume
36,800
Trading Value
0.13B JPY 0.85M USD
VWAP
3517.07 JPY 22.99 USD
Minimum Trading Value
354,500 JPY 2,317 USD
Market Cap
0.13T JPY 0.85B USD
Number of Trades
157
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
113
1-Year High Nov 4, 2025
649
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 8,300 13,600 1.64
Jan 16, 2026 7,500 14,100 1.88
Jan 9, 2026 3,700 19,700 5.32
Dec 26, 2025 1,600 9,100 5.69
Dec 19, 2025 2,300 9,500 4.13
Company Profile
Mochida Pharmaceutical Co., Ltd. is a mid-tier pharmaceutical company. Its main product is a medication for hyperlipidemia. The company has strengths in antihypertensive drugs and obstetrics and gynecology products. It also operates in the healthcare sector.
Sector
Pharmaceuticals
While the pharmaceutical-related business is the company's core operation, accounting for the majority of its sales, Mochida Pharmaceutical also engages in the healthcare business. In the pharmaceutical-related business, the company outsources manufacturing to its subsidiary, Mochida Pharmaceutical Plant Co., Ltd., and handles the procurement and sales of these products. Some pharmaceuticals are sold through Mochida Pharmaceutical Sales Co., Ltd. In the healthcare business, the subsidiary Mochida Healthcare Co., Ltd. is responsible for product procurement and sales. Manufacturing for healthcare products is also outsourced to Mochida Pharmaceutical Plant Co., Ltd., similar to pharmaceuticals. The group also includes subsidiaries that handle real estate brokerage, management of buildings and structures, and provide proxy services for accounting and purchasing operations, which Mochida Pharmaceutical also utilizes.